SCPH(Delisted)
Scpharmaceuticals·NASDAQ
--
--(--)
SCPH fundamentals
Scpharmaceuticals (SCPH) released its earnings on Aug 7, 2025: revenue was 16.00M (YoY +98.76%), beat estimates; EPS was -0.34 (YoY +22.73%), missed estimates.
Revenue / YoY
16.00M
+98.76%
EPS / YoY
-0.34
+22.73%
Report date
Aug 7, 2025
SCPH Earnings Call Summary for Q2,2025
- Revenue surge: Q2 2025 net revenue up 99% YoY to $16 million, driven by 45% QoQ dose growth and nephrology expansion.
- Strategic momentum: Auto-injector SNDA submission on track, IDN segment outperforming, and ASM program aligning with FUROSCIX's clinical value.
- Financial health: GTN discount rising to 30% in Q3, but cash position stable at $40.8 million with options to bolster liquidity.
- Growth catalysts: CMS Part D dynamics reducing patient co-pays, faster nephrology adoption, and Class IV heart failure clinic penetration.
EPS
Revenue
Revenue & Expenses
SCPH has released its 2025 Q2 earnings report, with revenue of 16.04M, reflecting a YoY change of 99.17%, and net profit of -18.02M, showing a YoY change of -5.47%. The Sankey diagram below clearly presents SCPH's revenue sources and cost distribution.
Key Indicators
Scpharmaceuticals (SCPH) key financial stats and ratios, covering profitability, financial health, and leverage.
Scpharmaceuticals (SCPH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Scpharmaceuticals (SCPH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Scpharmaceuticals (SCPH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Scpharmaceuticals (SCPH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Scpharmaceuticals (SCPH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
